main-logo

ICD-10 Code D07.2 | Carcinoma in situ of vagina Symptoms, Diagnosis, Billing

Carcinoma in situ of the vagina is a non-invasive malignancy characterized by abnormal cell growth confined to the vaginal epithelium. It is often associated with human papillomavirus (HPV) infection and requires careful monitoring due to its potential progression to invasive cancer. The ICD-10 Code D07.2 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring appropriate management and treatment strategies are implemented.

What is ICD-10 Code D07.2 for Carcinoma in situ of vagina?

ICD-10 Code D07.2 specifically denotes carcinoma in situ of the vagina, indicating the presence of abnormal cells that have not invaded surrounding tissues. This code is essential for clinical documentation and billing, particularly when diagnosing patients with precancerous lesions that may require further intervention or monitoring.

ICD-10 Code D07.2 – Clinical Definition and Explanation of Carcinoma in situ of vagina

Carcinoma in situ of the vagina arises from the vaginal epithelium and is primarily linked to HPV infection. It is crucial to identify and treat this condition promptly to prevent progression to invasive cancer. Regular screening and follow-up are essential for affected patients.

Key Clinical Features:

  • Asymptomatic in early stages, often discovered during routine examinations.
  • Possible presentation of abnormal vaginal bleeding or discharge.
  • Associated with HPV infection, particularly types 16 and 18.
  • Requires histological confirmation through biopsy for diagnosis.

ICD-10 Code D07.2 for Carcinoma in situ of vagina – SOAP Notes & Clinical Use

ICD-10 Code D07.2 is utilized in SOAP notes to document the diagnosis of carcinoma in situ of the vagina, guiding clinical assessments and treatment plans. It plays a vital role in both acute and chronic care settings, ensuring comprehensive patient management.

What Does ICD-10 Code D07.2 for Carcinoma in situ of vagina Mean in SOAP Notes?

In SOAP notes, ICD-10 Code D07.2 connects subjective patient reports and objective clinical findings to a formal diagnosis of carcinoma in situ of the vagina. This code is crucial for ensuring continuity of care, supporting billing processes, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code D07.2 – Carcinoma in situ of vagina

Prompt treatment of carcinoma in situ of the vagina is essential to prevent progression to invasive cancer. Surgical intervention is typically the primary approach.

Antibiotic Therapy:

    Supportive Care:

    • Regular gynecological follow-ups to monitor for progression.
    • Patient education on HPV vaccination and screening.
    • Psychosocial support for patients facing cancer-related anxiety.

    Infection Control:

      How to Document Symptoms of Carcinoma in situ of vagina (ICD-10 D07.2) in SOAP Notes

      Subjective:

      • Patient reports no symptoms but is concerned about abnormal Pap results.
      • History of HPV infection noted.
      • No significant vaginal bleeding or discharge reported.
      • Patient expresses anxiety regarding potential cancer diagnosis.

      Objective:

      • Pelvic examination reveals no visible lesions.
      • Pap smear shows atypical squamous cells.
      • Biopsy confirms carcinoma in situ.
      • Vital signs within normal limits.
      card-topcard-bottom

      Secure, compliant, and built for trust

      HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

      Learn more
      hipaa-icon

      SOAP Note Guidelines for Diagnosing Carcinoma in situ of vagina (ICD-10 Code D07.2)

      Assessment:

      • Diagnosis: Carcinoma in situ of vagina, confirmed by biopsy.
      • Severity: Non-invasive, localized.
      • Contributing factors: HPV infection.
      • Regular monitoring recommended.

      Plan:

      • Refer for surgical evaluation for excision.
      • Educate patient on HPV vaccination.
      • Schedule follow-up in 6 months for re-evaluation.
      • Discuss potential psychological support resources.

      Treatment & Plan Section for ICD-10 Code D07.2 – Carcinoma in situ of vagina

      • Surgical excision is the primary treatment option.
      • Regular follow-up appointments for monitoring.
      • Patient education on HPV prevention strategies.
      • Psychosocial support services may be beneficial.

      Using ICD-10 Code D07.2 for Carcinoma in situ of vagina in Billing & SOAP Note Compliance

      • Ensure accurate documentation of symptoms and findings in SOAP notes.
      • Use D07.2 in conjunction with relevant CPT codes for surgical procedures.
      • Maintain compliance with clinical guidelines for treatment plans.
      • Document patient education and follow-up plans to support billing.

      ICD-10 Code D07.2 in Medical Billing and Insurance for Carcinoma in situ of vagina

      ICD-10 Code D07.2 is critical in medical billing, particularly in hospital and outpatient settings, to ensure accurate claims for carcinoma in situ of the vagina.

      Billing Notes:

      • Document all relevant clinical findings to support the use of D07.2.
      • Ensure the code is used in appropriate settings, such as gynecological consultations.
      • Include detailed notes on patient education and follow-up care.
      • Utilize D07.2 in conjunction with procedure codes for surgical interventions.

      Common CPT Pairings:

      CPT CodeDescription
      58150Total abdominal hysterectomy, with or without salpingo-oophorectomy.
      57460Colposcopy of the vagina.
      88305Pathology examination of tissue, including biopsy.

      Frequently Asked Questions

      Common Questions About Using ICD-10 Code D07.2 for Carcinoma in situ of vagina

      What are the risk factors for carcinoma in situ of the vagina?

      Risk factors include HPV infection, particularly high-risk types, a history of cervical dysplasia, and immunosuppression. Regular screening is essential for early detection.

      How is carcinoma in situ of the vagina diagnosed?

      Diagnosis typically involves a pelvic examination, Pap smear, and biopsy to confirm the presence of abnormal cells confined to the vaginal epithelium.

      What treatment options are available for carcinoma in situ of the vagina?

      Treatment primarily involves surgical excision of the affected tissue. Regular follow-up and monitoring are also crucial to prevent progression to invasive cancer.

      Is carcinoma in situ of the vagina contagious?

      No, carcinoma in situ is not contagious. However, HPV, which can lead to this condition, is a sexually transmitted infection.

      diamond-bg
      diamond-bg

      Get started with your 20 free notes

      Sign up for free
      main-logo

      AI-aided Sudsy Shorthand for ink-free practices

      support@soapsuds.io
      hipaa-logo

      Clinical Notes

      SOAP notes

      DAP notes

      AI medical notes

      © Copyright SOAPsuds 2025. All rights reserved